Blog

Tian Zhang: Fantastic pearls of wisdom for clinical researchers from Neeraj Agarwal

Collage photo of Tian Zhang and Neeraj Agarwal

Oct 20, 2024, 17:29

Tian Zhang: Fantastic pearls of wisdom for clinical researchers from Neeraj Agarwal

Tian Zhang, shared a post on X by Umang Swami, Assistant Professor in the Division of Oncology at the Huntsman Cancer Institute, University of Utah, adding:

“Fantastic pearls of wisdom for clinical researchers from Neeraj Agarwal — busy clinic, enroll well, and have healthy balance of trials (phase and sponsor type) in portfolio. Looks like a fantastic SWOG meeting.“

Quoting Umang Swami’s post:

“A must to listen, fantastic talk for young investigators by Neeraj Agarwal on The Art of Patient Enrollment in Genitourinary Oncology Clinical Trials.“

More posts featuring Tian Zhang.

Dr. Tian Zhang, an Associate Director of Clinical Research at Simmons Comprehensive Cancer Center and an Associate Professor at UT Southwestern Medical Center, specializes in diagnosing and treating genitourinary cancers, including kidney, prostate, bladder, and testicular cancers. She focuses on clinical trials and translational research to develop new therapies and evaluate biomarkers for these malignancies. Dr. Zhang is a member of ASCO, AACR, and ESMO.

Umang Swami is an Assistant Professor in the Division of Oncology at the Huntsman Cancer Institute, University of Utah, specializing in medical oncology with a focus on genitourinary cancers. He earned his medical degree from Sawai Man Singh Medical College in India and gained research experience as a Visiting Scientist at the Montefiore-Einstein Cancer Center in New York, where he worked on phase I studies for advanced solid tumors.

Neeraj Agarwal is a Professor of Medicine, and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), University of Utah. He also directs the Genitourinary Oncology (GU) Program, and the Center of Investigational Therapeutics (CIT) at the HCI. Dr. Agarwal is an Advisor to the Oncology Drug Advisory Committee and the United States Food and Drug Administration, leads early therapeutics in the SWOG genitourinary cancers committee, and is the Chief Editor of ASCO Daily News.